Coronavirus: latest information
Grove Front Entrance
Professor Steve Bain

Professor Steve Bain

Professor in Medicine(Diabetes), Medicine

Telephone number

+44 (0) 1792 602205

Email address

Research Links

Office - 123
Ground Floor
Grove Building
Singleton Campus
Available For Postgraduate Supervision

About

Professor Steve Bain is Assistant Medical Director for Research & Development for Swansea Bay University Health Board and Clinical Director of the Diabetes Research Unit in Swansea University.


After undergraduate training at St John's College, Cambridge, he was clinically trained at King's College Hospital, London. Qualifying in 1983, he held junior appointments in London, East Midlands, and West Midlands. His research centred on the genetics of type 1 diabetes, and he was granted a Medical Research Council Lecturership. In 1993, he became a Senior Lecturer/Honorary Consultant Physician at Birmingham Heartlands Hospital, with promotion to Reader in Diabetic Medicine in 1998. Professor Bain became a Fellow of the Royal College of Physicians, UK, in 1996 and was appointed to a newly created Chair in Medicine (Diabetes) at Swansea University in 2005. His clinical interests include the genetics of diabetic nephropathy, new therapies for diabetes and the provision of diabetes services within the community. He has been Chief Investigator for several multi-centre trials investigating novel therapies for diabetes.


As a result of his genetics background, Professor Bain became a member of the inaugural West Midlands Multicentre Research Ethics Committee (MREC) and joined the UK Human Genetics Commission. From 2003-2008 he was HGC’s nomination on the National DNA Database Strategy Board and led the HGC report on DNA testing in 2009. In 2007 he was invited to sit on the newly formed National DNA Database Ethics Group, established by the Secretary of State for the Home Department. Professor Bain is Diabetes Lead Clinician for Swansea Bay University Health Board, a member of the Wales Diabetes & Endocrine Society (WEDS) executive committee and chaired the Specialist Training Committee for Diabetes & Endocrinology for Wales until 2016. He also chairs the Board which oversees the ILS Joint Clinical Research Facility, the premier clinical research institute in Wales.

Areas Of Expertise

  • Clinical management type 2 diabetes
  • Clinical management type 1 diabetes
  • Cardiovascular outcome trials of type 2 diabetes
  • Modern therapies for diabetes
  • Research & Development in the NHS
  • Peer review of scientific manuscripts and grant applications

Career Highlights

Teaching Interests

Diabetes Practice Masters, Swansea University – Course Clinical Lead

PMDM01 Diabetes Basics

PMDM05 Diabetes Management II

PMDM101 Diabetic Practice

PMZM17 Diabetes Management II

PMZM18 Diabetic Practice

PM-356 The Sweet Sickness: Advances in Diabetes and Related Disorders

 

 

 

 

Research

UK Chief Investigator for the following clinical trials:

ONWARDS 1 (2020-);

SOUL (2019-);

PIONEER 6 (2016-2019);

SUSTAIN 6 (2013-2016);

LEADER (2010-2016).

Award Highlights

MB BS 1983 Kings College Hospital, London
BA 1980 University of Cambridge
MA 1984 University of Cambridge
MRCP 1987 Royal College of Physicians, London
MD 1993 University of Birmingham
FRCP (UK) 1996 Royal College of Physicians, Edinburgh

Collaborations

Academic: See co-authors institutions on publications above

Education: Cardiff University, Doctors.net, Elsevier, Onmedica, Omnia-Med & Medscape

Industry: Abbott, Astra-Zeneka, Boehringer Ingelheim, BMS, Cellnovo, Diartis, Eli Lilly, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-aventis, Schering-Plough, Servier & Takeda